(Q33921108)

30 July 2017

1 reference

title

Augmentation of standard depression therapy (English)

1 reference

30 July 2017

Marangell LB

1

1 reference

30 July 2017

publication date

1 January 2000

1 reference

30 July 2017

published in

Clinical Therapeutics

1 reference

30 July 2017

volume

22 Suppl A

1 reference

30 July 2017

page(s)

A25-38; discussion A39-41

1 reference

Antidepressant medication change in a clinical treatment setting: a comparison of the effectiveness of selective serotonin reuptake inhibitors.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

Lack of change in fluoxetine and norfluoxetine kinetics when switching from fluoxetine to paroxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

Combination treatment with noradrenalin and serotonin reuptake inhibitors in resistant depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

Pharmacokinetic evaluation of co-administration of nefazodone and lithium in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

Lithium carbonate augmentation of antidepressant treatment. An effective prescription for treatment-refractory depression

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

The benefit of lithium carbonate adjunct in refractory depression--fact or fiction?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

Lithium augmentation therapy in tricyclic-resistant depression. A controlled trial using lithium in low and normal doses.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

Treatment of endogenous depressions resistant to tricyclic antidepressants or related drugs by lithium addition. Results of a placebo-controlled double-blind study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

The addition of lithium to carbamazepine. Antidepressant efficacy in treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

Olanzapine: interaction study with imipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

Failure of T3 to potentiate tricyclic antidepressant response

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

Thyroid Hormone and Tricyclic Antidepressants in Resistant Depressions

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

Cerebrospinal fluid amine metabolites after combined amitriptyline-triiodothyronine treatment of depressed women

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

Combined Therapy of T3 and Antidepressants in Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

Effectiveness of Pindolol With Selected Antidepressant Drugs in the Treatment of Major Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

Clinical Effects of the 5-HT1A Partial Agonists in Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

Buspirone augmentation of antidepressant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980071-5

7 January 2021

10.1016/S0149-2918(00)80071-5

Identifiers

DOI

1 reference

release_62wt44t6y5ajtn3655fz42gn6e

30 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/62wt44t6y5ajtn3655fz42gn6e

24 November 2022

mapped directly with Wikidata item

1 reference